<DOC>
	<DOCNO>NCT00158366</DOCNO>
	<brief_summary>This study determine effectiveness group-based behavioral program weight reduction overweight obese schizophrenia patient .</brief_summary>
	<brief_title>Reducing Weight Overweight Schizophrenia Patients</brief_title>
	<detailed_description>Researchers find link schizophrenia , high blood pressure , insulin resistance ; link put people schizophrenia increase risk diabetes obesity . Weight reduction maintenance essential decreasing risk . Although data indicate nonpharmacological intervention weight loss viable option , study determine effectiveness conduct . This study determine effectiveness behavioral training reduce weight schizophrenia patient . This study also determine effect weight reduction cardiovascular risk factor population . This study comprise two phase . In Phase 1 , participant randomly assign receive either behavioral training social skill train 14 week . The behavioral training teach participant way control diet increase physical activity . The social skill train teach participant indirectly control weight make social contact seek social support . After 14 week , participant social skill train group participant lose specified amount weight complete study ; participant behavioral train group 4 % weight loss enrol Phase 2 , 24-month program design help participant maintain weight loss . All participant Phase 2 continue receive weekly behavioral training , randomly assign receive either behavioral training alone behavioral training combine biweekly booster treatment participant discuss response different diet exercise regimens researcher discuss strategy increase one 's success regimen . Interviews , self-report scale , blood test use assess participant study entry , Phase 1 , end study . Assessments include quality life , self esteem , exercise frequency , blood pressure , serum lipid , blood glucose .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<criteria>Diagnosis schizophrenia schizoaffective disorder Body mass index ( BMI ) great 27 Stable antipsychotic drug regimen least 1 month prior study entry Parent guardian willing provide inform consent , applicable Positive negative syndrome scale score le 90 Willing use acceptable method contraception study Medical contraindication participate weight reduction/exercise program Mental retardation Current enrollment another weight management program Current use weight reduction medication Unstable cardiovascular thyroid disease Active endstage renal disease Psychiatric hospitalization within 1 month prior study entry Current use one antipsychotic medication Pregnancy breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Weight Loss</keyword>
</DOC>